Published August 11, 2026
| Version v1
Dataset
Open
Ordinal deep learning for pulmonary nodule risk assessment: an external validation study on a novel screening cohort
Authors/Creators
-
Cobo Cano, Miriam
(Data curator)1, 2
-
Serrano, Diego
(Contact person)3
-
Pasquier, Andrea
(Data collector)4
- Barranco, Jennifer (Annotator)4
-
de Torres, Juan Pablo
(Data collector)5
-
Zulueta, Javier J.
(Data collector)6, 7
-
Echeveste, Jose Ignacio
(Data collector)3
-
Ezponda, Ana
(Data collector)
- Pueyo, Jesus (Data collector)5
-
Argueta Morales, Allan
(Annotator)5
- et al. Show all 33 authors
Authors/Creators
-
Cobo Cano, Miriam
(Data curator)1, 2
-
Serrano, Diego
(Contact person)3
-
Pasquier, Andrea
(Data collector)4
- Barranco, Jennifer (Annotator)4
-
de Torres, Juan Pablo
(Data collector)5
-
Zulueta, Javier J.
(Data collector)6, 7
-
Echeveste, Jose Ignacio
(Data collector)3
-
Ezponda, Ana
(Data collector)
- Pueyo, Jesus (Data collector)5
-
Argueta Morales, Allan
(Annotator)5
- Sanz-Ortega, Julian5
-
Berto, Juan5
-
Alcaide Ocaña, Ana Belen
-
Di Frisco, Madeleine5
-
Felgueroso Rodero, Carmen5
-
Campo, Arantza
-
de la Fuente Añó, Alejandra
- Escobar, Ana5
-
Valencia, Karmele8
-
Orive Mauleón, Daniel
-
Ocon, Maria del Mar
- Globacka, Hanna Beata5
-
Fortuño, María-Antonia
-
Perna, Valerio5
- Rodríquez, María5
- Lozano, Maria D5
-
Calvo, Alfonso3
-
Pio, Ruben3, 9
-
Hung, Rayjean
-
Seijo, Luis5
-
Bastarrika Alemañ, Gorka5
-
Lloret Iglesias, Lara
(Project leader)
-
Montuenga, Luis M
(Project leader)
-
1.
Utrecht University
-
2.
Instituto de Física de Cantabria
-
3.
Universidad de Navarra
-
4.
Centro de Investigación Médica Aplicada
-
5.
Clinica Universidad de Navarra
-
6.
Icahn School of Medicine at Mount Sinai
-
7.
St. Luke's-Roosevelt Hospital Center
- 8. CIMA-University of Navarra
- 9. CIMA Universidad de Navarra
Description
This is a dataset for personalized low-dose CT-based lung cancer screening research. The dataset incorporates annotated screening low-dose computed tomography (LDCT) scans for a total of 211 screening participants. There are 67 lung cancer patients, 68 controls with benign pulmonary nodules, 71 controls without nodules and 5 surgically excised false positive lesions. For lung cancer cases, pathological gold standard label confirmed the presence and subtype of tumor.